SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Corbus Pharmaceuticals Q1 EPS $(0.430) Misses $(0.400) Estimate

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.430) per share which missed the analyst consensus estimate of $(0.400) by 7.5 percent. This is unchanged from the same period last year.

Benzinga · 05/11/2020 11:10

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.430) per share which missed the analyst consensus estimate of $(0.400) by 7.5 percent. This is unchanged from the same period last year.